Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Not only for larger gathering to show proper precautions where met but also every care home and hospital would want folks to be free of it before all letting them into a place with vulnerable people. Staff included. Travel as well as entry points to countries once the level under control.
Nice deduction and we will soon be in the territory of leak time :) Being here for over a year is without doubt the longest rollercoaster ride I have ever been on. Keep heading for the exciting rocket booster rise and loop the loop but before then momentum’s gained by a drop. Hands a raised in expectation
I wonder if they even considered us ? Probably only looked at what they can mine in the USA
Will be an interesting read on Sunday morning I think. Going to see how many times Avacta is mentioned at last.
British test British manufacture and British research and England on the TV . Think I might have a beer
right I have seen the list read the comments. Been holding for a year and living yet another weekend waiting for Monday. can we play guess the share price as my wife keeps saying. Yes heard that before and want to give her something to muse over :) End of May. 7.50
You wrote this for yourself but sums me up as well as I am sure lots of others on here! First ever venture into shares this year and what a year! No one would hold back the good news just to be sensitive re a funeral. What ever is happening as outside of Avacs capability to manage. They have no doubt got the thing as they have said. the need to get it validated is in somebodies jobs worth hands. how long and how fast they work? No idea.
Will they be rushing this? No reason to think they will. Like you I just need to see if this is actual give me some closure and putting the laptop down.
Keep listening and looking at various outlooks especially the long term Cancer and no matter the length of time there is a short medium and long term prospects for here which bode well for shareholders as well as those who become ill. Shorter £7.50- £10. Medium £15+. Long term 20+